ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Favipiravir Tablets Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-13S11667
Home | Market Reports | Health| Pharmacy
Global Favipiravir Tablets Market Research Report 2022
BUY CHAPTERS

Global Favipiravir Tablets Market Research Report 2025

Code: QYRE-Auto-13S11667
Report
February 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla Ltd
Lupin Ltd
Sun Pharma
Hisun Pharm

The global market for Favipiravir Tablets was valued at US$ 2351 million in the year 2024 and is projected to reach a revised size of US$ 3198 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Favipiravir Tablets Market

Favipiravir Tablets Market

Favipiravir is an antiviral drug which has been licenced in Japan since 2014 to treat influenza. It works by inhibiting a viral enzyme called RNA polymerase, preventing viral replication within human cells. This viral enzyme is common to several viruses, including SARS-CoV-2, which causes COVID-19. The drug has shown positive results against SARS-CoV-2 in laboratory and animal studies, with small pilot studies in humans demonstrating some benefit in reducing symptoms and the duration of illness.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Favipiravir Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Favipiravir Tablets.
The Favipiravir Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Favipiravir Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Favipiravir Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Favipiravir Tablets Market Report

Report Metric Details
Report Name Favipiravir Tablets Market
Accounted market size in year US$ 2351 million
Forecasted market size in 2031 US$ 3198 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma, Hisun Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Favipiravir Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Favipiravir Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Favipiravir Tablets Market growing?

Ans: The Favipiravir Tablets Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Favipiravir Tablets Market size in 2031?

Ans: The Favipiravir Tablets Market size in 2031 will be US$ 3198 million.

Who are the main players in the Favipiravir Tablets Market report?

Ans: The main players in the Favipiravir Tablets Market are ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma, Hisun Pharm

What are the Application segmentation covered in the Favipiravir Tablets Market report?

Ans: The Applications covered in the Favipiravir Tablets Market report are Influenza Viruses, COVID-19, Others

What are the Type segmentation covered in the Favipiravir Tablets Market report?

Ans: The Types covered in the Favipiravir Tablets Market report are Brand Drug, Generic Drug

Recommended Reports

Antiviral Therapies

COVID-19 Treatment

Virus Diagnostics

1 Favipiravir Tablets Market Overview
1.1 Product Definition
1.2 Favipiravir Tablets by Type
1.2.1 Global Favipiravir Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Favipiravir Tablets by Application
1.3.1 Global Favipiravir Tablets Market Value by Application (2024 VS 2031)
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Tablets Market Size Estimates and Forecasts
1.4.1 Global Favipiravir Tablets Revenue 2020-2031
1.4.2 Global Favipiravir Tablets Sales 2020-2031
1.4.3 Global Favipiravir Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Favipiravir Tablets Market Competition by Manufacturers
2.1 Global Favipiravir Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Favipiravir Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Favipiravir Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Favipiravir Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Favipiravir Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Favipiravir Tablets, Product Type & Application
2.7 Global Key Manufacturers of Favipiravir Tablets, Date of Enter into This Industry
2.8 Global Favipiravir Tablets Market Competitive Situation and Trends
2.8.1 Global Favipiravir Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Favipiravir Tablets Players Market Share by Revenue
2.8.3 Global Favipiravir Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Favipiravir Tablets Market Scenario by Region
3.1 Global Favipiravir Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Favipiravir Tablets Sales by Region: 2020-2031
3.2.1 Global Favipiravir Tablets Sales by Region: 2020-2025
3.2.2 Global Favipiravir Tablets Sales by Region: 2026-2031
3.3 Global Favipiravir Tablets Revenue by Region: 2020-2031
3.3.1 Global Favipiravir Tablets Revenue by Region: 2020-2025
3.3.2 Global Favipiravir Tablets Revenue by Region: 2026-2031
3.4 North America Favipiravir Tablets Market Facts & Figures by Country
3.4.1 North America Favipiravir Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Favipiravir Tablets Sales by Country (2020-2031)
3.4.3 North America Favipiravir Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Favipiravir Tablets Market Facts & Figures by Country
3.5.1 Europe Favipiravir Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Favipiravir Tablets Sales by Country (2020-2031)
3.5.3 Europe Favipiravir Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Favipiravir Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Favipiravir Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Favipiravir Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Favipiravir Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Favipiravir Tablets Market Facts & Figures by Country
3.7.1 Latin America Favipiravir Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Favipiravir Tablets Sales by Country (2020-2031)
3.7.3 Latin America Favipiravir Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Favipiravir Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Favipiravir Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Favipiravir Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Favipiravir Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Favipiravir Tablets Sales by Type (2020-2031)
4.1.1 Global Favipiravir Tablets Sales by Type (2020-2025)
4.1.2 Global Favipiravir Tablets Sales by Type (2026-2031)
4.1.3 Global Favipiravir Tablets Sales Market Share by Type (2020-2031)
4.2 Global Favipiravir Tablets Revenue by Type (2020-2031)
4.2.1 Global Favipiravir Tablets Revenue by Type (2020-2025)
4.2.2 Global Favipiravir Tablets Revenue by Type (2026-2031)
4.2.3 Global Favipiravir Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Favipiravir Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Favipiravir Tablets Sales by Application (2020-2031)
5.1.1 Global Favipiravir Tablets Sales by Application (2020-2025)
5.1.2 Global Favipiravir Tablets Sales by Application (2026-2031)
5.1.3 Global Favipiravir Tablets Sales Market Share by Application (2020-2031)
5.2 Global Favipiravir Tablets Revenue by Application (2020-2031)
5.2.1 Global Favipiravir Tablets Revenue by Application (2020-2025)
5.2.2 Global Favipiravir Tablets Revenue by Application (2026-2031)
5.2.3 Global Favipiravir Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Favipiravir Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ChemRar Group
6.1.1 ChemRar Group Company Information
6.1.2 ChemRar Group Description and Business Overview
6.1.3 ChemRar Group Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ChemRar Group Favipiravir Tablets Product Portfolio
6.1.5 ChemRar Group Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Company Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glenmark Favipiravir Tablets Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Company Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fujifilm Favipiravir Tablets Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Dr. Reddy
6.4.1 Dr. Reddy Company Information
6.4.2 Dr. Reddy Description and Business Overview
6.4.3 Dr. Reddy Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dr. Reddy Favipiravir Tablets Product Portfolio
6.4.5 Dr. Reddy Recent Developments/Updates
6.5 R-Pharma
6.5.1 R-Pharma Company Information
6.5.2 R-Pharma Description and Business Overview
6.5.3 R-Pharma Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 R-Pharma Favipiravir Tablets Product Portfolio
6.5.5 R-Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cipla Favipiravir Tablets Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Lupin
6.7.1 Lupin Company Information
6.7.2 Lupin Description and Business Overview
6.7.3 Lupin Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lupin Favipiravir Tablets Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sun Pharma Favipiravir Tablets Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hisun Pharm
6.9.1 Hisun Pharm Company Information
6.9.2 Hisun Pharm Description and Business Overview
6.9.3 Hisun Pharm Favipiravir Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hisun Pharm Favipiravir Tablets Product Portfolio
6.9.5 Hisun Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Favipiravir Tablets Industry Chain Analysis
7.2 Favipiravir Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Favipiravir Tablets Production Mode & Process Analysis
7.4 Favipiravir Tablets Sales and Marketing
7.4.1 Favipiravir Tablets Sales Channels
7.4.2 Favipiravir Tablets Distributors
7.5 Favipiravir Tablets Customer Analysis
8 Favipiravir Tablets Market Dynamics
8.1 Favipiravir Tablets Industry Trends
8.2 Favipiravir Tablets Market Drivers
8.3 Favipiravir Tablets Market Challenges
8.4 Favipiravir Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla Ltd
Lupin Ltd
Sun Pharma
Hisun Pharm
List of Tables
 Table 1. Global Favipiravir Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Favipiravir Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Favipiravir Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Favipiravir Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Favipiravir Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Favipiravir Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Favipiravir Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Favipiravir Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Favipiravir Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Favipiravir Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Favipiravir Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Favipiravir Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Favipiravir Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Favipiravir Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Favipiravir Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Favipiravir Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Favipiravir Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Favipiravir Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Favipiravir Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Favipiravir Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Favipiravir Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Favipiravir Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Favipiravir Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Favipiravir Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Favipiravir Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Favipiravir Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Favipiravir Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Favipiravir Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Favipiravir Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Favipiravir Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Favipiravir Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Favipiravir Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Favipiravir Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Favipiravir Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Favipiravir Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Favipiravir Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Favipiravir Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Favipiravir Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Favipiravir Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Favipiravir Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Favipiravir Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Favipiravir Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Favipiravir Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Favipiravir Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Favipiravir Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Favipiravir Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Favipiravir Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Favipiravir Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Favipiravir Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Favipiravir Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Favipiravir Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Favipiravir Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Favipiravir Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Favipiravir Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Favipiravir Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Favipiravir Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Favipiravir Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Favipiravir Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Favipiravir Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Favipiravir Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Favipiravir Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Favipiravir Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Favipiravir Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Favipiravir Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Favipiravir Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Favipiravir Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Favipiravir Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. ChemRar Group Company Information
 Table 71. ChemRar Group Description and Business Overview
 Table 72. ChemRar Group Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. ChemRar Group Favipiravir Tablets Product
 Table 74. ChemRar Group Recent Developments/Updates
 Table 75. Glenmark Company Information
 Table 76. Glenmark Description and Business Overview
 Table 77. Glenmark Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Glenmark Favipiravir Tablets Product
 Table 79. Glenmark Recent Developments/Updates
 Table 80. Fujifilm Company Information
 Table 81. Fujifilm Description and Business Overview
 Table 82. Fujifilm Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fujifilm Favipiravir Tablets Product
 Table 84. Fujifilm Recent Developments/Updates
 Table 85. Dr. Reddy Company Information
 Table 86. Dr. Reddy Description and Business Overview
 Table 87. Dr. Reddy Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Dr. Reddy Favipiravir Tablets Product
 Table 89. Dr. Reddy Recent Developments/Updates
 Table 90. R-Pharma Company Information
 Table 91. R-Pharma Description and Business Overview
 Table 92. R-Pharma Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. R-Pharma Favipiravir Tablets Product
 Table 94. R-Pharma Recent Developments/Updates
 Table 95. Cipla Company Information
 Table 96. Cipla Description and Business Overview
 Table 97. Cipla Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Cipla Favipiravir Tablets Product
 Table 99. Cipla Recent Developments/Updates
 Table 100. Lupin Company Information
 Table 101. Lupin Description and Business Overview
 Table 102. Lupin Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Lupin Favipiravir Tablets Product
 Table 104. Lupin Recent Developments/Updates
 Table 105. Sun Pharma Company Information
 Table 106. Sun Pharma Description and Business Overview
 Table 107. Sun Pharma Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sun Pharma Favipiravir Tablets Product
 Table 109. Sun Pharma Recent Developments/Updates
 Table 110. Hisun Pharm Company Information
 Table 111. Hisun Pharm Description and Business Overview
 Table 112. Hisun Pharm Favipiravir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hisun Pharm Favipiravir Tablets Product
 Table 114. Hisun Pharm Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Favipiravir Tablets Distributors List
 Table 118. Favipiravir Tablets Customers List
 Table 119. Favipiravir Tablets Market Trends
 Table 120. Favipiravir Tablets Market Drivers
 Table 121. Favipiravir Tablets Market Challenges
 Table 122. Favipiravir Tablets Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Favipiravir Tablets
 Figure 2. Global Favipiravir Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Favipiravir Tablets Market Share by Type: 2024 & 2031
 Figure 4. Brand Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Favipiravir Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Favipiravir Tablets Market Share by Application: 2024 & 2031
 Figure 8. Influenza Viruses
 Figure 9. COVID-19
 Figure 10. Others
 Figure 11. Global Favipiravir Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Favipiravir Tablets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Favipiravir Tablets Sales (2020-2031) & (K Units)
 Figure 14. Global Favipiravir Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 15. Favipiravir Tablets Report Years Considered
 Figure 16. Favipiravir Tablets Sales Share by Manufacturers in 2024
 Figure 17. Global Favipiravir Tablets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Favipiravir Tablets Players: Market Share by Revenue in Favipiravir Tablets in 2024
 Figure 19. Favipiravir Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Favipiravir Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Favipiravir Tablets Sales Market Share by Country (2020-2031)
 Figure 22. North America Favipiravir Tablets Revenue Market Share by Country (2020-2031)
 Figure 23. United States Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Favipiravir Tablets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Favipiravir Tablets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Favipiravir Tablets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Favipiravir Tablets Revenue Market Share by Region (2020-2031)
 Figure 34. China Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Favipiravir Tablets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Favipiravir Tablets Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Favipiravir Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Favipiravir Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Favipiravir Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Favipiravir Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Favipiravir Tablets by Type (2020-2031)
 Figure 55. Global Favipiravir Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Favipiravir Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Favipiravir Tablets by Application (2020-2031)
 Figure 58. Global Favipiravir Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 59. Favipiravir Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Respiratory Antiviral Treatment Market Research Report 2024
Global Oseltamivir Phosphate API Market Research Report 2025
Protease Inhibitors Market
Influenza Antiviral Drugs Market
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
Global Antiviral Combination Therapies Market Research Report 2024
Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specific Antiviral Drugs for COVID 19 Market
Global Arbidol Tablets COVID 19 Market Research Report 2024
Oseltamivir Phosphate Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valacyclovir API Market Research Report 2025
Global Favipiravir Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Efavirenz API Market Research Report 2025
Global Antiviral Drugs for Influenza Market Research Report 2025
Global Oral Antiviral Medications for COVID 19 Market Research Report 2025
Ribavirin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Papillomaviru Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Viral Pneumonia Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molnupiravir Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions